The effect of aclidinium on symptoms including cough in chronic obstructive pulmonary disease: A phase 4, double-blind, placebo-controlled, parallel-group study

Smith, Jaclyn A.; McGarvey, Lorcan; Morice, Alyn H.; Birring, Surinder S.; Wedzicha, Jadwiga A.; Notari, Massimo; Zapata, Antonio; Segarra, Rosa; Seoane, Beatriz; Jarreta, Diana

doi:10.1164/rccm.201901-0048LE

The effect of aclidinium on symptoms including cough in chronic obstructive pulmonary disease: A phase 4, double-blind, placebo-controlled, parallel-group study

Smith, Jaclyn A.; McGarvey, Lorcan; Morice, Alyn H.; Birring, Surinder S.; Wedzicha, Jadwiga A.; Notari, Massimo; Zapata, Antonio; Segarra, Rosa; Seoane, Beatriz; Jarreta, Diana

Authors

Jaclyn A. Smith

Lorcan McGarvey

Professor Alyn Morice A.H.Morice@hull.ac.uk
Foundation Chair and Professor of Respiratory Medicine

Surinder S. Birring

Jadwiga A. Wedzicha

Massimo Notari

Antonio Zapata

Rosa Segarra

Beatriz Seoane

Diana Jarreta

Citation

Smith, J. A., McGarvey, L., Morice, A. H., Birring, S. S., Wedzicha, J. A., Notari, M., Zapata, A., Segarra, R., Seoane, B., & Jarreta, D. (2019). The effect of aclidinium on symptoms including cough in chronic obstructive pulmonary disease: A phase 4, double-blind, placebo-controlled, parallel-group study. American Journal of Respiratory and Critical Care Medicine, 200(5), 642-645. https://doi.org/10.1164/rccm.201901-0048LE

Journal Article Type	Letter
Acceptance Date	Apr 5, 2019
Online Publication Date	Sep 1, 2019
Publication Date	Sep 1, 2019
Deposit Date	May 10, 2022
Publicly Available Date	May 19, 2022
Journal	American Journal of Respiratory and Critical Care Medicine
Print ISSN	1073-449X
Publisher	American Thoracic Society
Peer Reviewed	Peer Reviewed
Volume	200
Issue	5
Pages	642-645
DOI	https://doi.org/10.1164/rccm.201901-0048LE
Public URL	https://hull-repository.worktribe.com/output/3609532

Files

Published article (564 Kb)
PDF

Publisher Licence URL
https://creativecommons.org/licenses/by-nc-nd/4.0/

Copyright Statement
This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/).